GRI Bio Corporation - GRI Operating Margin

Corporate company logo of GRI Bio Corporation (GRI)

Monitoring the operating profitability of GRI Bio, Inc. (GRI) reveals a trend where the 0.00 level indicates the state of the efficiency parameter. The business relies on external CRO and CMO contractors, delegating all clinical processes to them. High bioengineering costs and strict oversight create significant barriers to entry. The environmental vector is limited by compliance with medical regulations and the disposal of chemical waste.

GRI: GRI Bio Profitability of Operations 02/21/2024 - 11/19/2026

GRI Bio, Inc. - analytical breakdowns and key metrics (GRI)

- stock quotes and analyst forecast:
Initial company analysis:GRI, GRI Bio, Inc.
Brand item of GRI Bio Corporation

GRI Bio, Inc. is currently in the clinical trial stage for immunotherapy drugs, with revenues primarily generated through grants. This metric measures core business efficiency via the ratio of operating profit to revenue, reflecting the company's ability to cover expenses before taxes and interest. The negative trend in the operating profit margin confirms a stage of high investment, signaling potential capital drawdown risks to the investor.

Competing companies

ARGX (argenx N.V.) - Operating Margin|Operating Return on Sales BioNTech Pharma BNTX|Operating Sales Margin ABVX (ABIVAX)|Operating Margin ADMA Biologics, Inc. (ADMA)|Operating Margin PTGX (protagonist-inc.com)|IMVT: Return on Sales by Operating Profit|KNSA - Operating Profitability|GRFS: Operating Profitability|ADPT (Adaptive Biotechnologies) - Operating Sales Margin|Return on Sales by Operating Profit CLDX|Operating Sales Margin AUPH|BCRX (BioCryst Pharmaceuticals) - Operating Profit Ratio|Operating Profitability Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Operating Profit Rate|Pharvaris N.V. - Operating Sales Margin|Operating Profit Rate ABCL|TRML: Operating Sales Margin|PGEN (Precigen) - Return on Sales by Operating Profit|pharming.com (PHAR) - Operating Profitability|Nektar Corp (NKTR) - Operating Margin|UPB (upstreambio.com) - Operating Margin|ZBIO: Operating Profit Rate|Operating Margin IMNM|Profitability of Operations Gossamer Bio Inc|Operating Margin KALV (KalVista Pharma)|SEPN (Septerna Pharma) - Operating Profit Margin|PVLA: Operating Sales Margin|Operating Profit Margin SVRA|RIGL: Operating Margin|Return on Sales by Operating Profit ANAB|ATXS (Astria Corp) - Operating Margin|Return on Sales by Operating Profit ENGN (enGene Bio)|Operating Margin RAPT|Profitability of Operations Aerovate Therapeutics|Operating Profitability Aclaris Therapeutics Inc. ACRS|Profitability of Operations Kyverna Therapeutics Inc. (KYTX)|TLSA - Operating Profitability|CABA: Operating Profitability|VTYX (Ventyx Biosciences, Inc.) - Operating Sales Margin|THTX - Profitability of Operations|AVTX (avalotx.com) - Operating Margin|Operating Return on Sales Eledon Pharmaceuticals Inc. ELDN|Operating Margin AGEN|CLYM (Climb Bio, Inc.) - Operating Profit Rate|Operating Profitability zurabio.com ZURA|ATYR - Operating Sales Margin|Adagene Inc - Operating Margin|ImageneBio (IMA) - Operating Sales Margin|Shattuck Therapeutics (STTK) - Operating Profitability|Operating Return on Sales Equillium Inc (EQ)|Operating Sales Margin CNTB|Return on Sales by Operating Profit IMUX (Immunic, Inc.)|Operating Profitability Atara Biotherapeutics, Inc. (ATRA)|IFRX - Operating Return on Sales|Profitability of Operations XFOR|Profitability of Operations Adicet (ACET)|CELU - Operating Profitability|INMB (INmune Bio, Inc.) - Return on Sales by Operating Profit|BRNS: Operating Margin|Kezar Life Sciences Inc. (KZR) - Operating Margin|Operating Profitability SAB Biotherapeutics Inc|Operating Margin Akari Therapeutics, Plc|Operating Profitability Enlivex Therapeutics Ltd (ENLV)|QTTB - Operating Return on Sales|Operating Margin GOVX (GeoVax Corp)|Edesa Biotech (EDSA) - Operating Return on Sales|iBio Corporation - Operating Margin|CARM (carismatx.com) - Return on Sales by Operating Profit|XTLB (XTL Bio) - Operating Sales Margin|Operating Return on Sales Bolt Biotherapeutics Inc. (BOLT)|Operating Sales Margin HCWB|Aptevo Therapeutics Inc. - Operating Profit Margin|Operating Profitability AIM ImmunoTech, Inc. (AIM)|Operating Margin Aditxt Corp (ADTX)|Operating Margin XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Operating Return on Sales|Revelation Biosciences Corp - Operating Margin|INDP (Indaptus Therapeutics, Inc.) - Return on Sales by Operating Profit|SCNI: Operating Margin|CALI - Profitability of Operations|AFMD (Affimed N.V.) - Operating Margin|Operating Profitability ALLK|Operating Sales Margin HOOK (HOOKIPA Pharma, Inc.)|IGMS - Operating Return on Sales|Operating Profitability iTeos ITOS|Ocean Bio - Operating Profitability|TC BioPharm Ltd - Operating Margin|Operating Return on Sales thirdharmonicbio.com